Johnson & Johnson saga reveals critical strengths in the U.S. COVID-19 mass-vaccination strategy — and its weaknesses
April 14, 2021 at 00:04 AM EDT
‘Part of Operation Warp Speed was not knowing which ones would cross the finish line,’ said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security.
